Clinical Trial Update: Ketamine and Nitroprusside for Depression [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating ketamine and nitroprusside for depression has completed, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)
• Nitroprusside (nitroprusside)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Depression | Phase 2 | Status: COMPLETED | Results posted: 2020-07-02